Disclosure Under Regulation 30 of SEBI
Successful USFDA Update of Unit 2 (07.02.2020)
Related Party Disclosure_ Half Year ended- (31-03-2019)
Rating Rationale from CARE Ratings Ltd (02 August 2019)
Successful USFDA Update of Unit 1 (21-06-2019)
Disclosure under Regulation 30 of SEBI (Update)
Disclosure under Regulation 30 of SEBI
Rating Rationale from CARE Ratings Ltd
Successful USFDA Inspection of Unit 2 (29-11-18)
Neuland Acquires New Facility (13-12-17)
Update on Purchase of Manufacturing Facility (12-12-17)
Update on Nanakramguda Project (21-05-17)
The Listing Agreement Pertaining to Media Companies and/or their Associates
Draft Letter of Offer (26-03-14)
Letter of Offer (20-03-12)
